Valuation : Paion AG

Market Cap 144K 167K 135K 123K 232K 15.98M 233K 1.6M 625K 8.07M 628K 614K 26.75M P/E 2021
-3.89x
P/E 2022 -53x
Enterprise Value 9.87M 11.45M 9.25M 8.45M 15.91M 1.09B 15.96M 110M 42.82M 552M 42.99M 42.06M 1.83B EV / Sales 2021
14.1x
EV / Sales 2022 1.22x
Free-Float
100%
Yield 2021 *
-
Yield 2022 -
1 week+4.35%
Current month-12.73%
1 month-12.73%
3 months-9.43%
6 months-31.43%
Current year+263.64%
1 week 0.05
Extreme 0.046
0.05
1 month 0.04
Extreme 0.044
0.06
Current year 0.01
Extreme 0.012
0.23
1 year 0.01
Extreme 0.009
0.23
3 years 0
Extreme 0.0001
5.56
5 years 0
Extreme 0.0001
20.15
10 years 0
Extreme 0.0001
36.78
Manager TitleAgeSince
Chief Executive Officer 62 01/09/2023
Director of Finance/CFO - 01/06/2022
Director TitleAgeSince
Director/Board Member 65 01/10/2012
Director/Board Member 75 01/06/2017
Director/Board Member - 22/05/2019
Date Insider Type Main position Quantity % Market Cap.
27/12/22 Buy

Director

1,121 0.0016%
12/1/21 Buy

Chief Executive Officer

8,500 0.0127%
8/6/20 Buy

Chief Executive Officer

13,158 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
+25.00%+4.35%+433.33%-98.99% 399K
-0.78%-1.42%+2.49%+22.78% 51.14B
-5.88%-0.76%+442.36%+544.33% 47.4B
-0.07%+0.89%+38.89%+18.19% 43.19B
-1.73%-2.41%+22.65%+80.84% 42.35B
-0.31%-1.75%+17.23%+52.37% 33.23B
-1.54%-3.15%+27.12%+129.78% 17.07B
-0.93%-2.55% - - 16.38B
-0.88%-0.66%+11.60%+27.75% 14.76B
-1.58%-0.98%+79.08%+47.06% 14.15B
Average -1.38%+1.06%+119.42%+91.57% 27.97B
Weighted average by Cap. -1.74%+1.12%+98.98%+137.51%

Financials

2021 2022
Net sales 7.13M 8.27M 6.68M 6.1M 11.49M 791M 11.53M 79.29M 30.94M 399M 31.06M 30.38M 1.32B 33.25M 38.58M 31.17M 28.46M 53.61M 3.69B 53.78M 370M 144M 1.86B 145M 142M 6.17B
Net income -21.79M -25.28M -20.43M -18.65M -35.13M -2.42B -35.24M -242M -94.55M -1.22B -94.92M -92.86M -4.04B -579K -672K -543K -496K -934K -64.22M -937K -6.44M -2.51M -32.42M -2.52M -2.47M -107M
Net Debt 13.77M 15.98M 12.91M 11.78M 22.2M 1.53B 22.27M 153M 59.76M 771M 59.99M 58.69M 2.56B 9.72M 11.28M 9.12M 8.32M 15.68M 1.08B 15.73M 108M 42.2M 544M 42.36M 41.44M 1.81B
Logo Paion AG
Paion AG is a Germany-based biopharmaceutical company. The Company's main product is remimazolam, an intravenous ultra-short-acting benzodiazepine sedative and anesthetic. In the human body, remimazolam is metabolized to an inactive metabolite by tissue esterase and not metabolized by cytochrome-dependent hepatic pathways. In addition to that, remimazolam, which is in Phase III clinical development, can be reversed with flumazenil to terminate sedation and anesthesia, if necessary. The product can be used for general anesthesia in Europe and procedural sedation in the United States. The Company operates sites in Aachen, Germany, Cambridge, the United Kingdom, and New Jersey, the United States.
Employees
64
Date Price Change Volume
27/08/26 0.0480 0.00% 0
26/08/26 €0.0480 +4.35% 23
25/08/26 €0.0460 0.00% 0
24/08/26 €0.0460 0.00% 0
21/08/26 €0.0460 0.00% 0
  1. Stock Market
  2. Stocks
  3. PA8K Stock